ZIM
HZNP

Zacks Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Zacks Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,940
Closed -$1.73M – 698
2023
Q3 		$1.73M Hold
14,940
– – 0.02% 298
2023
Q2 		$1.54M Hold
14,940
– – 0.02% 316
2023
Q1 		$1.63M Sell
14,940
-10
-0.1% -$1.1K 0.02% 309
2022
Q4 		$1.7M Sell
14,950
-1,270
-8% -$105K 0.02% 295
2022
Q3 		$1M Hold
16,220
– – 0.02% 342
2022
Q2 		$1.29M Buy
+16,220
New +$1.54M 0.02% 315
2020
Q4 		– Sell
-15,151
Closed -$1.18M – 602
2020
Q3 		$1.18M Buy
+15,151
New +$1.04M 0.02% 297
2019
Q3 		– Sell
-56,696
Closed -$1.36M – 620
2019
Q2 		$1.36M Hold
56,696
– – 0.03% 349
2019
Q1 		$1.5M Sell
56,696
-14,176
-20% -$336K 0.03% 311
2018
Q4 		$1.39M Sell
70,872
-16,491
-19% -$323K 0.03% 285
2018
Q3 		$1.71M Sell
87,363
-67,349
-44% -$1.28M 0.04% 308
2018
Q2 		$2.56M Buy
+154,712
New +$2.36M 0.06% 232
2016
Q2 		– Sell
-17,244
Closed -$286K – 745
2016
Q1 		$286K Buy
+17,244
New +$302K 0.01% 501
2015
Q3 		– Sell
-14,461
Closed -$502K – 713
2015
Q2 		$502K Buy
+14,461
New +$441K 0.02% 439

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zacks Investment Management's HZNP Position: Q4 2023 in Review

Zacks Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 14,940 shares — an estimated $1.73M sold.

Zacks Investment Management first reported a position in HZNP in Q2 2015 and held it in 14 quarters. The position peaked at $2.56M in Q2 2018. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Zacks Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Zacks Investment Management sold 14,940 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.73M.
  • Zacks Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 14 quarters.
  • Zacks Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.56M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Zacks Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.